论文部分内容阅读
肝细胞癌是一种常见的恶性肿瘤,其恶性程度高,发展迅速,且常合并肝硬化,超过75%的患者由于肿瘤的大小、位置等原因不能被手术根治性切除。对不可切除或不能耐受手术肝脏肿瘤患者而言,经皮乙醇瘤内注射是一种相对无创、设备简单、易操作的介入治疗手段,本研究通过观察肝细胞癌患者治疗前后肿瘤体积及血清甲胎蛋白的变化,探讨对肝细胞癌患者经皮乙醇瘤内注射的临床效果。1资料与方法1.1临床资料52例患者为我院2005年12月~2013年11
Hepatocellular carcinoma is a common malignant tumor with high malignant degree and rapid development. It is often associated with cirrhosis. More than 75% of patients can not be surgically removed due to tumor size, location and other reasons. For patients with unresectable or can not tolerate surgical liver tumors, percutaneous ethanol injection is a relatively noninvasive, simple device, easy intervention intervention in this study by observing the tumor volume before and after treatment of patients with hepatocellular carcinoma and serum A-fetoprotein changes in patients with hepatocellular carcinoma to study the clinical effect of percutaneous ethanol injection. 1 Materials and Methods 1.1 Clinical data 52 patients for our hospital in December 2005 ~ 2013 11